Thomas Martin Vernon
Director/Board Member at IOMAI CORPORATION
Network origin in Thomas Martin Vernon first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Martin Vernon via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal | |
Hoechst Corp
Hoechst Corp Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst Corp is a pharmaceutical concern. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOVAVAX, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
MAXCYTE, INC. | Biotechnology | Director/Board Member Chairman | |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Director/Board Member Founder | |
R.J. Reynolds Tobacco Co.
R.J. Reynolds Tobacco Co. TobaccoConsumer Non-Durables R.J. Reynolds Tobacco Co. manufactures and markets tobacco products. The firm has tobacco-sheet manufacturing operations and a research-and-development facility in Winston-Salem. Its brands include Camel, Kool, Pall Mall, Winston, Doral, Barclay, Lucky Strike, and Monarch. The company was founded in 1875 and is headquartered in Winston-Salem, NC. | Tobacco | Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree | |
Boston University | College/University | Doctorate Degree | |
George Washington University | College/University | Masters Business Admin | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
Vienna University of Economics & Business | College/University | Doctorate Degree | |
University of Vienna | College/University | Graduate Degree | |
Washington State University | College/University | Doctorate Degree | |
University of Paisley | College/University | Undergraduate Degree | |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Director of Finance/CFO | |
REDX PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Glaxo Laboratories Ltd.
Glaxo Laboratories Ltd. Medical DistributorsDistribution Services Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK. | Medical Distributors | Director of Finance/CFO | |
VALNEVA | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO | |
Johns Hopkins Bloomberg School of Public Health | College/University | Corporate Officer/Principal Graduate Degree | |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
QSpine Ltd.
QSpine Ltd. Medical SpecialtiesHealth Technology QSpine Ltd. designs, manufactures and distributes medical devices in the surgical spine market segment. Its products include Mobi-C, sterispine pedicle screw, sterispine lumber cage and spinetune and shivas cervical cage. The company was founded by Forbes Butterfield and Stuart Hunter Carmichael in 2011 and is headquartered in Corby, the United Kingdom. | Medical Specialties | Director/Board Member | |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Chemicals: Specialty | Director/Board Member | |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Valneva Sweden AB
Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Director/Board Member | |
Intercell Austria AG | Corporate Officer/Principal Chief Executive Officer | ||
Valneva UK Ltd.
Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Valneva Canada, Inc.
Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member President Director/Board Member | |
Stuart & Muir Consulting Ltd. | Director/Board Member | ||
Agprome Ltd. | Director/Board Member | ||
Synpromics Agbiosub Ltd.
Synpromics Agbiosub Ltd. Miscellaneous Commercial ServicesCommercial Services Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
HOOKIPA PHARMA INC. | Biotechnology | Director of Finance/CFO | |
Grätzelmixer GmbH | Chief Executive Officer | ||
Valneva USA, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer | ||
ACM Biolabs Pte Ltd.
ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | Biotechnology | Director/Board Member |
Statistics
International
United States | 25 |
United Kingdom | 13 |
Austria | 8 |
France | 3 |
Sweden | 3 |
Sectoral
Health Technology | 22 |
Consumer Services | 13 |
Commercial Services | 4 |
Distribution Services | 3 |
Producer Manufacturing | 2 |
Operational
Director/Board Member | 74 |
Corporate Officer/Principal | 45 |
Chief Executive Officer | 21 |
Chairman | 16 |
Director of Finance/CFO | 14 |
Most connected contacts
Insiders | |
---|---|
David Lawrence | 29 |
Jeff Himawan | 24 |
Franck Grimaud | 22 |
R. Gordon Douglas | 21 |
Thomas Lingelbach | 17 |
Stanley Erck | 10 |
Richard Douglas | 10 |
Reinhard Kandera | 10 |
Gregory Glenn | 7 |
F. Weller Meyer | 6 |
Russell Wilson | 6 |
Jin Sook Chung | 6 |
Sarah A. Frech | 5 |
Robert C. Seid | 5 |
Kai Chen | 4 |
- Stock Market
- Insiders
- Thomas Martin Vernon
- Company connections